Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 2/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.34 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | CD44 | P16070 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL102596 | 0.79 | CBFB (0.37) | MAPT | |
| SCHEMBL31540633 | 0.79 | — | — | |
| SCHEMBL3806197 | 0.79 | — | — | |
| Water SCHEMBL28270232 | 0.78 | CBFB (0.36) | MAPT | |
| SCHEMBL28425752 | 0.76 | — | — | |
| SCHEMBL1021251 | 0.76 | KDM4E (0.37) | MAPTLMNA | |
| SCHEMBL2291635 | 0.76 | RPS6KA3 (0.44) | JAK2 | |
| SCHEMBL27510266 | 0.76 | HSP90AA1 (0.32) | — | |
| SCHEMBL21563201 | 0.76 | — | — | |
| SCHEMBL1020657 | 0.76 | GRM4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101812358-A | High-temperature chain oil composition of mixed base oil | MASUDA RISSOIL BEIJING CHEMICALS CO LTD | 2010-08-25 | — | — | CN | claimed |
| CN-101696369-A | High-temperature chain oil composition | MASUDA RISSOIL BEIJING CHEMICA | 2010-04-21 | — | — | CN | claimed |
| JP-61002794-A | — | — | None | — | — | JP | disclosed |
| WO-2025053212-A1 | RAW MATERIAL FOR RELEASE FILM, REGENERATED RELEASE FILM, AND METHODS FOR PRODUCING THESE | 住友ベークライト株式会社 | 2025-03-13 | — | — | WO | disclosed |
| WO-2024184520-A1 | BIARYLAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-09-12 | — | — | WO | disclosed |
| US-20210277003-A1 | OGA INHIBITOR COMPOUNDS | JANSSEN PHARMACEUTICA NV (BE) | 2021-09-09 | — | — | US | disclosed |
| CN-109642028-B | Resin composition | 东丽株式会社 | 2021-06-25 | — | — | CN | disclosed |
| US-9563004-B2 | Image source unit and image display unit | DAI NIPPON PRINTING CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160103262-A1 | IMAGE SOURCE UNIT AND IMAGE DISPLAY UNIT | DAI NIPPON PRINTING CO., LTD. (JP) | 2016-04-14 | — | — | US | disclosed |
| US-9244204-B2 | Image source unit and image display unit | DAI NIPPON PRINTING CO., LTD. (JP) | 2016-01-26 | — | — | US | disclosed |
| EP-2121858-B1 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | ARKEMA INC (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-2121824-B1 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | ARKEMA INC (US) | 2011-01-12 | — | — | EP | disclosed |
| US-20100324169-A1 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES, INC (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100319579-A1 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | ARKEMA INC. | 2010-12-23 | — | — | US | disclosed |
| EP-2121858-A2 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-25 | — | — | EP | disclosed |
| EP-2121824-A2 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008100608-A2 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT | DOW GLOBAL TECHNOLOGIES, INC (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008100607-A2 | METHOD FOR REDUCING PLATE OUT OF AQUEOUS COATING COMPOSITIONS | DOW GLOBAL TECHNOLOGIES, INC (US) | 2008-08-21 | — | — | WO | disclosed |
| US-4642221-A | AROMATIC TRIAZOLES AND IMINODICARBOXYLIC ACID DERIVATIVES | ATLANTIC RICHFIELD COMPANY (US) | 1987-02-10 | — | — | US | disclosed |
| JP-S612794-A | METHOD OF IMPROVING STORAGE STABILITY OF FUEL OIL | FUJI SEKIYU KK | 1986-01-08 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210277003-A1 | OGA INHIBITOR COMPOUNDS | OGA, OGT, GRN | MAPT 7/4885LMNA 848/4885POLB 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.